Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Probiotics for Radiation Side Effects in Colorectal Cancer
NCT03742596Phase 3Withdrawn
- Sponsor
- King Hussein Cancer Center
- Start
- Nov 2018
- Primary completion
- Sep 2022
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial (2 arms), sponsored by King Hussein Cancer Center. Primary endpoints: Immunoglobulin A, Immunoglobulin G and 6 more. Planned start Nov 2018; status: withdrawn.
Beyond the preview
Go deeper on NCT03742596.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03742596.